Manufacturing

Pharmaceutical contract manufacturing in Uzbekistan: how it works

Updated 14 September 2026 · Laxisam Pharmaceuticals

Contract manufacturing in Uzbekistan has moved out of the niche. A growing domestic market, preferences for locally made products in public tenders and mandatory GMP from 2027 have turned a local site into a practical market-entry tool. Here is how cooperation is structured and what is required from the customer.

Three main models

Cooperation formats with a manufacturing site
ModelEssenceBest suited for
Contract manufacturing (CMO)Production to the customer's documentation under the customer's brandCompanies with a complete dossier and brand
Licensed productionManufacturing a partner's product under transferred technology, usually with local registrationForeign manufacturers localising a portfolio
Private labelProduction under the customer's brand based on the site's own developmentDistributors and pharmacy chains building an own brand

What the customer provides

  1. Complete technological documentation: composition, raw material and finished product specifications, control methods.
  2. Analytical methods with validation details and, where required, reference standards.
  3. Stability data, or agreement to run stability studies at the site.
  4. Packaging requirements and artwork reflecting local labelling rules.
  5. Regulatory status: registration in the country of origin, quality certificates.

What the site provides

Available dosage forms and capacity

The site profile defines which products can be manufactured at all. Laxisam Pharmaceuticals capabilities:

Dosage forms, batch sizes, available capacity and timelines are confirmed after a technical assessment. Send the formulation, planned volume, packaging requirements and target market for review.

Dosage forms, batch sizes, available capacity and timelines are confirmed after a technical assessment. Send the formulation, planned volume, packaging requirements and target market for review.

How the process usually runs

  1. Feasibility assessment: review of the form, composition and equipment requirements.
  2. Non-disclosure agreement and exchange of technical documentation.
  3. Commercial terms and contract, including a Quality Agreement.
  4. Technology transfer: process adaptation and trial runs at the site.
  5. Validation batches confirming reproducible quality.
  6. Regulatory actions — registration or variation.
  7. Routine commercial production and ongoing quality control.

Why Uzbekistan

Frequently asked questions

How does contract manufacturing differ from licensed production?
In contract manufacturing the site produces to the customer's documentation under the customer's brand. Licensed production involves transferring the partner's technology and usually a local registration. The key difference is who holds the marketing authorisation.
Which dosage forms are available?
Dosage forms, batch sizes, available capacity and timelines are confirmed after a technical assessment. Send the formulation, planned volume, packaging requirements and target market for review.
What is the production capacity?
Dosage forms, batch sizes, available capacity and timelines are confirmed after a technical assessment. Send the formulation, planned volume, packaging requirements and target market for review.
Does the site hold a GMP certificate?
The site operates according to GMP principles. Request current quality documentation and its scope for the proposed project from Laxisam.
What is needed to start?
Technological documentation, analytical methods, stability data, packaging requirements and the regulatory status of the product.